Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP6817697B2 - Soap-based skin cleanser and storage stability improvement method - Google Patents
[go: Go Back, main page]

JP6817697B2 - Soap-based skin cleanser and storage stability improvement method - Google Patents

Soap-based skin cleanser and storage stability improvement method Download PDF

Info

Publication number
JP6817697B2
JP6817697B2 JP2015242224A JP2015242224A JP6817697B2 JP 6817697 B2 JP6817697 B2 JP 6817697B2 JP 2015242224 A JP2015242224 A JP 2015242224A JP 2015242224 A JP2015242224 A JP 2015242224A JP 6817697 B2 JP6817697 B2 JP 6817697B2
Authority
JP
Japan
Prior art keywords
extract
fatty acid
soap
mass
based skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015242224A
Other languages
Japanese (ja)
Other versions
JP2017105737A (en
Inventor
恵理香 吉田
恵理香 吉田
松江 由香子
由香子 松江
哲朗 岩永
哲朗 岩永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kracie Home Products Ltd
Original Assignee
Kracie Home Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kracie Home Products Ltd filed Critical Kracie Home Products Ltd
Priority to JP2015242224A priority Critical patent/JP6817697B2/en
Publication of JP2017105737A publication Critical patent/JP2017105737A/en
Application granted granted Critical
Publication of JP6817697B2 publication Critical patent/JP6817697B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Description

本発明は石けん系皮膚洗浄剤および保存安定性向上方法に関する。詳細には、低温環境下で透明を保ち、泡質・泡量が良好である石けん系皮膚洗浄剤、及び石けん系皮膚洗浄剤の低温環境下における保存安定性を向上させる方法に関する。 The present invention relates to a soap-based skin cleanser and a method for improving storage stability. More specifically, the present invention relates to a soap-based skin cleansing agent that remains transparent in a low-temperature environment and has good foam quality and amount, and a method for improving the storage stability of the soap-based skin cleansing agent in a low-temperature environment.

従来の液体洗浄剤は、サッパリとした洗い上がりの感触を重視し、カリウム石けんを原料として用いることが一般的であった。しかしながら、このようなカリウム石けんを原料として含む液体洗浄剤は、カリウム石けんや未中和の脂肪酸がクラフト点以下の温度環境下において析出してしまい、外観が白濁するという問題が生じていた。 Conventional liquid cleaning agents generally use potassium soap as a raw material with an emphasis on a refreshing feel after washing. However, such a liquid cleaning agent containing potassium soap as a raw material has a problem that potassium soap and unneutralized fatty acids are precipitated in a temperature environment below the Krafft point, and the appearance becomes cloudy.

これらの問題を解決するため、従来の石けん系皮膚洗浄剤では、低温下で透明を保つことを実現することを目的に、分鎖飽和アルキル基をもつ非イオン界面活性剤、ベタイン型両性界面活性剤、アミンオキサイド系界面活性剤などを配合することが提案されている(例えば、特許文献1、2参照)。 In order to solve these problems, conventional soap-based skin cleansers are nonionic surfactants having a chain-saturated alkyl group and betaine-type amphoteric surfactants for the purpose of maintaining transparency at low temperatures. It has been proposed to add an agent, an amine oxide-based surfactant, or the like (see, for example, Patent Documents 1 and 2).

特開2007−326820号JP-A-2007-326820 特開平9−157154号JP-A-9-157154

しかしながら、従来技術で提案されたこれらの透明な石けん系皮膚洗浄剤の低温環境下における透明性は1ヶ月時点での保存安定性に留まり(特許文献1、2参照)、寒暖の差が激しい日本の温度環境ではこの期間のみで安定性を担保することは難しいという問題があった。 However, the transparency of these transparent soap-based skin cleansers proposed in the prior art in a low temperature environment remains stable at one month (see Patent Documents 1 and 2), and the temperature difference is large in Japan. There was a problem that it was difficult to ensure stability only during this period in the temperature environment of.

本発明者らは上記問題点を鑑みて鋭意研究した結果、エタノール、直鎖脂肪酸アルカノールアミド型非イオン界面活性剤(但し、直鎖脂肪酸モノエタノールアミド型非イオン界面活性剤は除く)、エタノール、および特定の脂肪酸組成を有するカリ石けん及び水を組み合わせることにより、これまでの問題点を解決できることを見出し、本発明を完成するに至った。 As a result of diligent research in view of the above problems, the present inventors have found that ethanol, linear fatty acid alkanolamide type nonionic surfactant (excluding linear fatty acid monoethanolamide type nonionic surfactant), ethanol, We have found that the problems so far can be solved by combining potassium soap and water having a specific fatty acid composition, and have completed the present invention.

すなわち、本発明はエタノール、直鎖脂肪酸アルカノールアミド型非イオン界面活性剤(但し、直鎖脂肪酸モノエタノールアミド型非イオン界面活性剤は除く)、および特定の脂肪酸組成を有するカリ石けん及び水を組み合わせることを特徴とする石けん系皮膚洗浄剤である。 That is, the present invention combines ethanol, a linear fatty acid alkanolamide-type nonionic surfactant (excluding the linear fatty acid monoethanolamide-type nonionic surfactant), and potassium soap and water having a specific fatty acid composition. It is a soap-based skin cleanser characterized by this.

さらに本発明は、直鎖型脂肪酸アルカノールアミド型非イオン界面活性剤(但し、直鎖脂肪酸モノエタノールアミド型非イオン界面活性剤は除く)およびエタノールを、脂肪酸および脂肪酸のカリウム塩からなる石けん系皮膚洗浄剤に配合することにより、石けん系皮膚洗浄剤の低温環境下における透明性を維持する方法である。 Furthermore, the present invention comprises a linear fatty acid alkanolamide type nonionic surfactant (excluding the linear fatty acid monoethanolamide type nonionic surfactant) and ethanol, and soap-based skin composed of a fatty acid and a potassium salt of the fatty acid. It is a method of maintaining the transparency of a soap-based skin cleaning agent in a low temperature environment by blending it with a cleaning agent.

さらに上記石けん系皮膚洗浄剤において特定の脂肪酸組成を有するカリ石けんの脂肪酸組成がラウリン酸15〜45質量%、ミリスチン酸10〜40質量%、パルミチン酸0〜3
5質量%であり、前記脂肪酸及びそのカリウム塩を合計で15〜40質量%含有し、脂肪酸:カリウム塩の質量比が1:99〜0:100であることが好ましい。また、エタノールの配合量は石けん系皮膚洗浄剤全量に対し、3〜10質量%であることが望ましい。また、直鎖脂肪酸アルカノールアミド型非イオン界面活性剤(但し、直鎖脂肪酸モノエタノールアミド型非イオン界面活性剤は除く)の配合量は石けん系皮膚洗浄剤全量に対し、2〜5質量%であることが望ましい。
Further, in the above soap-based skin cleansing agent, the fatty acid composition of potassium soap having a specific fatty acid composition is 15 to 45% by mass of lauric acid, 10 to 40% by mass of myristic acid, and 0 to 3 palmitic acid.
It is preferably 5% by mass, containing 15 to 40% by mass of the fatty acid and its potassium salt in total, and the mass ratio of fatty acid: potassium salt is 1:99 to 0: 100. The amount of ethanol compounded is preferably 3 to 10% by mass with respect to the total amount of the soap-based skin cleanser. The amount of the linear fatty acid alkanolamide-type nonionic surfactant (excluding the linear fatty acid monoethanolamide-type nonionic surfactant) is 2 to 5% by mass based on the total amount of the soap-based skin cleanser. It is desirable to have.

本発明によれば、低温で長期間透明性を保ち(0℃、3ヶ月)、泡質・泡量が良好である石けん系皮膚洗浄剤を提供することができる。 また石けん系皮膚洗浄剤の低温環境下における透明性を維持する方法を提供することができる。 According to the present invention, it is possible to provide a soap-based skin cleansing agent that maintains transparency for a long period of time at a low temperature (0 ° C., 3 months) and has good foam quality and amount. It is also possible to provide a method for maintaining the transparency of a soap-based skin cleanser in a low temperature environment.

以下、本発明を詳細に説明する。 Hereinafter, the present invention will be described in detail.

本発明の石けん系皮膚洗浄剤に使用するエタノールはアルコール類である。エタノールの配合量は石けん系皮膚洗浄剤全量に対し、3〜10質量%が必要であり、好ましくは4〜7質量%である。 The ethanol used in the soap-based skin cleanser of the present invention is alcohol. The blending amount of ethanol is required to be 3 to 10% by mass, preferably 4 to 7% by mass, based on the total amount of the soap-based skin cleanser.

本発明の石けん系皮膚洗浄剤に使用する直鎖脂肪酸アルカノールアミド型非イオン界面活性剤は親水基と親油基がアミド結合した非イオン界面活性剤である。直鎖脂肪酸アルカノールアミド型非イオン界面活性剤の配合量は石けん系皮膚洗浄剤全量に対し3〜5質量%必要であり、好ましくは3〜4質量%である。
直鎖脂肪酸アルカノールアミド型非イオン界面活性剤(直鎖脂肪酸モノエタノールアミド型非イオン界面活性剤は、本発明における直鎖脂肪酸アルカノールアミド型非イオン界面活性剤の対象から除く)の配合量が3質量%未満の場合は低温安定性が悪化し、直鎖脂肪酸アルカノールアミド型非イオン界面活性剤の配合量が5質量%より多い場合は極度に増粘し、剤の水溶けなど使用性に不具合が生じてしまう。
The linear fatty acid alkanolamide-type nonionic surfactant used in the soap-based skin cleaning agent of the present invention is a nonionic surfactant in which a hydrophilic group and a base oil group are amide-bonded. The blending amount of the linear fatty acid alkanolamide type nonionic surfactant is required to be 3 to 5% by mass, preferably 3 to 4% by mass, based on the total amount of the soap-based skin cleansing agent.
The amount of the linear fatty acid alkanolamide type nonionic surfactant (the linear fatty acid monoethanolamide type nonionic surfactant is excluded from the target of the linear fatty acid alkanolamide type nonionic surfactant in the present invention) is 3 If it is less than 5% by mass, the low temperature stability deteriorates, and if the amount of the linear fatty acid alkanolamide type nonionic surfactant is more than 5% by mass, the viscosity becomes extremely thick, and the usability such as water solubility of the agent is deteriorated. Will occur.

本発明の石けん系皮膚洗浄剤に使用する特定の脂肪酸組成を有するカリ石けんは、陰イオン系カルボン酸が他界面活性剤である。特定の脂肪酸組成を有するカリ石けんの脂肪酸の配合量は石けん系皮膚洗浄剤全量に対し、ラウリン酸15〜45質量%、ミリスチン酸10〜40質量%、パルミチン酸0〜35質量%が必要であり、好ましくはラウリン酸20〜40質量%、ミリスチン酸15〜35質量%、パルミチン酸5〜30質量%である。これらの脂肪酸は、それぞれ高純度の脂肪酸を前記のような脂肪酸組成となるように混合して用いてもよく、あるいはヤシ油脂肪酸、パーム核油脂肪酸、パーム油脂肪酸のような混合脂肪酸を用い、これに適宜構成脂肪酸を加えて前記の脂肪酸組成となるようにしてもよい。混合脂肪酸を用いた場合、カプリル酸、カプリン酸、アラキン酸、ベヘニン酸、ステアリン酸、オレイン酸、リノール酸、イソステアリン酸等が少量混ざってくることがあるが、本発明の効果を損なわない範囲であるなら構わない。 The potash soap having a specific fatty acid composition used in the soap-based skin cleansing agent of the present invention has an anionic carboxylic acid as another surfactant. The amount of fatty acid in potash soap having a specific fatty acid composition requires 15 to 45% by mass of lauric acid, 10 to 40% by mass of myristic acid, and 0 to 35% by mass of palmitic acid with respect to the total amount of soap-based skin cleaning agent. Lauric acid is preferably 20 to 40% by mass, myristic acid is 15 to 35% by mass, and palmitic acid is 5 to 30% by mass. As these fatty acids, high-purity fatty acids may be mixed and used so as to have the above-mentioned fatty acid composition, or mixed fatty acids such as coconut oil fatty acid, palm kernel oil fatty acid, and palm oil fatty acid may be used. Constituent fatty acids may be appropriately added thereto to obtain the above-mentioned fatty acid composition. When a mixed fatty acid is used, a small amount of caprylic acid, capric acid, araquinic acid, behenic acid, stearic acid, oleic acid, linoleic acid, isostearic acid, etc. may be mixed, but the effect of the present invention is not impaired. It doesn't matter if there is.

本発明の石けん系皮膚洗浄剤には、前記脂肪酸及びそのカリウム塩を合計で15〜40質量%、好ましくは20〜30質量%配合し、脂肪酸:脂肪酸のカリウム塩の質量比は1:99〜0:100であり、好ましくは0.5:99.5〜0:100である。これらの範囲外では、低温で透明を保ち(0℃3ヶ月)、泡質・泡量が良好であることはできない。 The soap-based skin cleaning agent of the present invention contains the fatty acid and its potassium salt in a total amount of 15 to 40% by mass, preferably 20 to 30% by mass, and the mass ratio of fatty acid: potassium salt of fatty acid is 1:99 to It is 0: 100, preferably 0.5: 99.5 to 0: 100. Outside these ranges, it cannot remain transparent at low temperatures (0 ° C for 3 months) and have good foam quality and foam volume.

本発明の石けん系皮膚洗浄剤に使用する水は、純水である。水の配合量は石けん系皮膚洗浄剤全量に対し、45〜75質量%が必要であり、好ましくは60〜70質量%である。 The water used in the soap-based skin cleanser of the present invention is pure water. The blending amount of water is required to be 45 to 75% by mass, preferably 60 to 70% by mass, based on the total amount of the soap-based skin cleansing agent.

本発明の石けん系皮膚洗浄剤は、前記の組成となる脂肪酸及びそのカリウム塩をそれぞれ
配合することにより製造することができるが、典型的には60〜90℃に加温した水酸化カリウムを含む水溶液に、60〜90℃に加温融解した過剰量の脂肪酸を含む油相を撹拌しつつ加え、この石けん水溶液の温度が50℃以下でエタノール及び直鎖脂肪酸アルカノールアミド型非イオン界面活性剤に分散させた水溶性高分子を加えていき、充分に分散させる方法で製造することができ、pH9〜10になるように調整することが好ましい。
The soap-based skin cleaning agent of the present invention can be produced by blending a fatty acid having the above composition and a potassium salt thereof, respectively, and typically contains potassium hydroxide heated to 60 to 90 ° C. An oil phase containing an excess amount of fatty acid heated and thawed at 60 to 90 ° C. was added to the aqueous solution with stirring, and the soap aqueous solution was added to an ethanol and linear fatty acid alkanolamide type nonionic surfactant at a temperature of 50 ° C. or lower. It can be produced by a method of adding a dispersed water-soluble polymer and sufficiently dispersing it, and it is preferable to adjust the pH to 9 to 10.

本発明の石けん系皮膚洗浄剤は、上述した成分の他に、本発明の目的を損なわない範囲で他の成分、例えばアニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、ノニオン界面活性剤、カチオン化高分子、非イオン性高分子、粉体(顔料、色素、樹脂等)、防腐剤、香料、保湿剤、生理活性成分、塩類、溶媒、中和剤、pH調整剤、昆虫忌避剤、酵素等の成分を適宜配合することができる。 In addition to the above-mentioned components, the soap-based skin cleaning agent of the present invention contains other components, such as anionic surfactants, cationic surfactants, amphoteric surfactants, and nonionic surfactants, as long as the object of the present invention is not impaired. , Cationic polymer, nonionic polymer, powder (pigment, pigment, resin, etc.), preservative, fragrance, moisturizer, physiologically active ingredient, salts, solvent, neutralizer, pH adjuster, insect repellent , Enzymes and other components can be appropriately blended.

上記アニオン界面活性剤としては、特に限定されるものではなく、例えばα−ラウロイルスルホン酸ナトリウム、ミリストイルアリルスルホン酸ナトリウム、ラウリルナフタレンスルホン酸ナトリウム、ラウリル硫酸トリエタノールアミン、ラウリル硫酸アンモニウム、ラウリルエーテル硫酸ナトリウム、ポリオキシエチレンラウリルエーテル硫酸ナトリウム、ポリオキシエチレンヤシ油脂肪酸アミドエーテル硫酸カリウム、ラウリルリン酸ナトリウム、N−ヤシ油脂肪酸グルタミン酸カリウム、スルホコハク酸ラウリル二ナトリウム、ポリオキシエチレンラウリルエーテル酢酸ナトリウム等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The anionic surfactant is not particularly limited, and for example, α-sodium lauroyl sulfonate, sodium myristyl allyl sulfonate, sodium lauryl naphthalene sulfonate, triethanolamine lauryl sulfate, ammonium lauryl sulfate, sodium lauryl ether sulfate, etc. Examples thereof include sodium polyoxyethylene lauryl ether sulfate, potassium polyoxyethylene coconut oil fatty acid amide ether sulfate, sodium lauryl phosphate, potassium N-palm oil fatty acid glutamate, disodium lauryl sulfosuccinate, sodium polyoxyethylene lauryl ether acetate, and the like. One type or two or more types may be selected and used as appropriate.

上記両面界面活性剤としては、特に限定されるものではないが、例えばラウリン酸アミドプロピルベタイン、ヤシ油脂肪酸アミドプロピルベタイン、ラウリルジメチルアミノ酢酸ベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、ラウリルアミノジ酢酸ナトリウム、β−アミノプロピオン酸ナトリウム、N−ラウロイル−N′−カルボキシメチル−N′−ヒドロキシエチルエチレンジアミンナトリウム等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The double-sided surfactant is not particularly limited, and is, for example, lauric acid amide propyl betaine, coconut oil fatty acid amide propyl betaine, lauryldimethylaminoacetic acid betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethyl. Examples thereof include imidazolinium betaine, sodium laurylaminodiacetate, sodium β-aminopropionate, N-lauroyl-N'-carboxymethyl-N'-hydroxyethylethylenediamine sodium, etc., and one or more of them are appropriately selected and used. Just do it.

上記ノニオン界面活性剤としては、特に限定されるものではないが、例えばポリオキシエチレンセチルエーテル、モノステアリン酸ソルビタン、トリイソステアリン酸ポリオキシエチレンソルビタン、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンモノイソステアレート、ポリオキシエチレンジオレイン酸グリセリル、ヤシ油脂肪酸ジエタノールアミド、ヤシ油脂肪酸モノエタノールアミド、ヤシ油脂肪酸N−メチルエタノールアミド、ポリオキシエチレンポリオキシプロピレングリコールモノラウリン酸ポリエチレングリコール等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The nonionic surfactant is not particularly limited, but for example, polyoxyethylene cetyl ether, sorbitan monostearate, polyoxyethylene sorbitan triisostearate, polyoxyethylene hydrogenated coconut oil, and polyoxyethylene monoisosteer. Rate, glyceryl polyoxyethylene dioleate, coconut oil fatty acid diethanolamide, coconut oil fatty acid monoethanolamide, coconut oil fatty acid N-methylethanolamide, polyoxyethylene polyoxypropylene glycol monolaurate polyethylene glycol, etc. Alternatively, two or more types may be selected and used.

上記カチオン化高分子としては、特に限定されるものではないが、例えば塩化O−[2−ヒドロキシ−3−(トリメチルアンモニオ)プロピル]ヒドロキシエチルセルロース、塩化O−[2−ヒドロキシ−3−(トリメチルアンモニオ)プロピル]グァーガム、塩化ジメチルアリルアンモニウム・アクリルアミド共重合体、及びアクリルアミド・アクリル酸・塩化ジメチルジアリルアンモニウム共重合体等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The cationized polymer is not particularly limited, but for example, O- [2-hydroxy-3- (trimethylammonio) propyl] hydroxyethyl cellulose chloride and O- [2-hydroxy-3- (trimethyl) chloride. Ammonio) propyl] guar gum, dimethylallylammonium chloride / acrylamide copolymer, acrylamide / acrylic acid / dimethyldialylammonium chloride copolymer and the like can be mentioned, and one or more of them may be appropriately selected and used.

上記非イオン性高分子としては、特に限定されるものではないが、例えばヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ポリエチレングリコール、高重合ポリエチレングリコール、及びポリビニルアルコール等が挙げられ、適宜一種又は二種以上選択して用いればよい。 The nonionic polymer is not particularly limited, and examples thereof include hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, polyethylene glycol, highly polymerized polyethylene glycol, polyvinyl alcohol, and the like, and one or two as appropriate. You can select and use more than one species.

また、上記粉体としては、例えば赤色201号、黄色4号、青色1号、黒色401号等の色素、黄色4号A1レーキ、黄色203号Baレーキ等のレーキ色素、ナイロンパウダー
、シルクパウダー、シリコーンパウダー、セルロースパウダー、シリコーンエラストマー球状粉体、ポリエチレン末等の高分子、黄酸化鉄、赤色酸化鉄、酸化クロム、カーボンブラック、群青、紺青等の有色顔料、酸化亜鉛、酸化チタン等の白色顔料、タルク、マイカ、セリサイト、カオリン等の体質顔料、雲母チタン等のパール顔料、硫酸バリウム、炭酸カルシウム、炭酸マグネシウム、珪酸マグネシウム等の金属塩、シリカ、アルミナ等の無機粉体、ベントナイト、スメクタイト、窒化ホウ素等が挙げられる。これらの粉体の形状(球状、棒状、針状、板状、不定形状、燐片状、紡錘状等)に特に制限はない。
Examples of the powder include pigments such as Red No. 201, Yellow No. 4, Blue No. 1, Black No. 401, rake pigments such as Yellow No. 4 A1 Lake and Yellow No. 203 Ba Lake, nylon powder, and silk powder. Silicone powder, cellulose powder, silicone elastomer spherical powder, polymers such as polyethylene powder, colored pigments such as yellow iron oxide, red iron oxide, chromium oxide, carbon black, ultramarine blue, dark blue, and white pigments such as zinc oxide and titanium oxide. , Tarku, mica, sericite, kaolin and other extender pigments, mica titanium and other pearl pigments, barium sulfate, calcium carbonate, magnesium carbonate, magnesium silicate and other metal salts, silica, alumina and other inorganic powders, bentonite, smectite, Examples include boron nitride. The shape of these powders (spherical, rod-shaped, needle-shaped, plate-shaped, indefinite-shaped, fluff-shaped, spindle-shaped, etc.) is not particularly limited.

上記生理活性成分としては、皮膚に塗布した場合に皮膚に何らかの生理活性を与える物質が挙げられる。例えば、抗炎症剤、老化防止剤、紫外線防止剤、ひきしめ剤、抗酸化剤、保湿剤、血行促進剤、抗菌剤、殺菌剤、乾燥剤、冷感剤、温感剤、ビタミン剤、アミノ酸、創傷治癒促進剤、刺激残和剤、鎮痛剤、細胞賦活剤、酵素成分等が挙げられる。上記生理活性成分は、天然系の植物抽出成分、海藻抽出成分、生薬成分や、化合物等が挙げられるが、これらの中でも、特に天然系の植物抽出成分、海藻抽出成分、生薬成分が安全性の点で好ましい。 Examples of the physiologically active ingredient include substances that give some physiological activity to the skin when applied to the skin. For example, anti-inflammatory agents, anti-aging agents, UV protection agents, tightening agents, antioxidants, moisturizers, blood circulation promoters, antibacterial agents, bactericidal agents, desiccants, cooling agents, warming agents, vitamins, amino acids, Wound healing promoters, stimulant repellents, painkillers, cell activators, enzyme components and the like can be mentioned. Examples of the bioactive component include natural plant extract components, seaweed extract components, crude drug components, compounds, etc. Among these, natural plant extract components, seaweed extract components, and crude drug components are particularly safe. It is preferable in that.

上記天然系の植物抽出成分、海藻抽出成分、生薬成分の例としては、例えばアシタバエキス、アマチャエキス、アルテアエキス、アロエエキス、アンズエキス、イチョウエキス、ウイキョウエキス、ウーロン茶エキス、エイジツエキス、オウゴンエキス、オウバクエキス、オトギリソウエキス、オランダカラシエキス、オレンジエキス、海水乾燥物、海藻エキス、加水分解コムギ末、加水分解シルク、カモミラエキス、カロットエキス、カワラヨモギエキス、甘草エキス、カキョクエキス、キウイエキス、キューカンバーエキス、クチナシエキス、クマザサエキス、クララエキス、クルミエキス、グレープフルーツエキス、クロレラエキス、クワエキス、紅茶エキス、酵母エキス、コラーゲン、サルビアエキス、サボンソウエキス、サンザシエキス、ジオウエキス、シコンエキス、シソエキス、シナノキエキス、シャクヤクエキス、シラカバエキス、スギナエキス、セイヨウキズタエキス、セイヨウサンザシエキス、セイヨウニワトコエキス、セイヨウノコギリソウエキス、セイヨウハッカエキス、セージエキス、センキュウエキス、センブリエキス、タイソウエキス、タイムエキス、茶エキス、チョウジエキス、チンピエキス、トウキエキス、トウニンエキス、ドクダミエキス、トマトエキス、納豆エキス、ニンジンエキス、ニンニクエキス、ノバラエキス、蜂蜜、ハマメリスエキス、ヒキオコシエキス、ビサボロール、ビワエキス、ブクリョウエキス、プロポリス、ヘチマエキス、ペパーミントエキス、ボダイジュエキス、ホップエキス、マロニエエキス、ムクロジエキス、メリッサエキス、モモエキス、ユキノシタエキス、ユズエキス、ヨモギエキス、ラベンダーエキス、レモンエキス、レンゲソウエキス、ローズマリーエキス、ローヤルゼリーエキス等を挙げることができる。 Examples of the above-mentioned natural plant extract component, seaweed extract component, and crude drug component include, for example, Ashitaba extract, Amacha extract, Artea extract, Aloe extract, Anzu extract, Ginkgo extract, Wikyo extract, Woolong tea extract, Agetsu extract, Ogon extract, Oubaku extract, Otogirisou extract, Dutch mustard extract, orange extract, dried seawater, seaweed extract, hydrolyzed wheat powder, hydrolyzed silk, chamomile extract, carrot extract, kawarayomogi extract, licorice extract, kakyoku extract, kiwi extract, cucumber extract, Kuchinashi extract, Kumazasa extract, Clara extract, Walnut extract, Grapefruit extract, Chlorella extract, Kwa extract, Tea extract, Yeast extract, Collagen, Salvia extract, Sabonsou extract, Sanzashi extract, Jio extract, Shikon extract, Shiso extract, Shinanoki extract, Shakuyaku extract, Shirakaba extract, Sugina extract, Seiyoukizuta extract, Seiyousanzashi extract, Seiyouniwatoko extract, Seiyounokogirisou extract, Seiyouhakka extract, Sage extract, Senkyu extract, Senburi extract, Taisou extract, Thyme extract, Tea extract, Chouji extract, Chinpi extract, Touki Extract, Tounin extract, Dokudami extract, Tomato extract, Natto extract, Carrot extract, Garlic extract, Novara extract, Honey, Hamamelis extract, Hikiokoshi extract, Bisaborol, Biwa extract, Bukuryo extract, Propolis, Hechima extract, Peppermint extract, Bodaiju extract, Hop extract, Examples thereof include malonie extract, mukuroji extract, melissa extract, peach extract, yukinoshita extract, yuzu extract, yomogi extract, lavender extract, lemon extract, astragalus extract, rosemary extract, royal jelly extract and the like.

また、上記天然系の植物抽出成分、海藻抽出成分、生薬成分以外の成分としては、例えば、デオキシリボ核酸、ムコ多糖類、ヒアルロン酸ナトリウム、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、キチン、キトサン、加水分解卵殻膜等の生体高分子、アミノ酸、乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム、ベタイン、ホエイ等の保湿成分、スフィンゴ脂質、セラミド、コレステロール、コレステロール誘導体、リン脂質等の油性成分、ε−アミノカプロン酸、グリチルリチン酸、β−グリチルレチン酸、塩化リゾチーム、グアイアズレン、ヒドロコルチゾン等の抗炎症剤、ビタミン類(A、B2、B6、C、D、E)、パントテン酸カルシウム、ビオチン、ニコチン酸アミド、ビタミンCエステル等のビタミン類、アラントイン、ジイソプロピルアミンジクロロアセテート、4−アミノメチルシクロヘキサンカルボン酸等の活性成分、トコフェロール、カロチノイド、フラボノイド、タンニン、リグナン、サポニン等の抗酸化剤、α―ヒドロキシ酸、β−ヒドロキシ酸等の細胞賦活剤、γ−オリザノール、ビタミンE誘導体等の血行促進剤、イソプロピルメチルフェノール、トリクロサン、ヒノキチオール、塩化ベンザルコニウム等の殺菌剤、1−メントール、ハッカ油等の冷感剤、レチノール、レチノール誘導体
等の創傷治癒剤等が挙げられる。
Examples of components other than the above-mentioned natural plant extract components, seaweed extract components, and crude drug components include deoxyribonucleic acid, mucopolysaccharide, sodium hyaluronate, sodium chondroitin sulfate, collagen, elastin, chitin, chitosan, and hydrolyzed eggshell. Biopolymers such as membranes, amino acids, sodium lactate, urea, sodium pyrrolidone carboxylate, betaine, moisturizing ingredients such as whey, oily ingredients such as sphingolipids, ceramides, cholesterol, cholesterol derivatives, phospholipids, ε-aminocaproic acid, glycyrrhizin Anti-inflammatory agents such as acids, β-glycyrrhetinic acid, lysozyme chloride, guaiazulene, hydrocortisone, vitamins (A, B2, B6, C, D, E), calcium pantothenate, biotin, nicotinic acid amide, vitamin C ester, etc. Active ingredients such as vitamins, allantin, diisopropylamine dichloroacetate, 4-aminomethylcyclohexanecarboxylic acid, antioxidants such as tocopherol, carotinoid, flavonoid, tannin, lignan, saponin, α-hydroxy acid, β-hydroxy acid, etc. Cell activators, blood circulation promoters such as γ-orizanol and vitamin E derivatives, bactericides such as isopropylmethylphenol, triclosan, hinokithiol and benzalconium chloride, cold sensitizers such as 1-menthol and peppermint oil, retinol and retinol derivatives Wound healing agents and the like can be mentioned.

以下、本発明を実施例及び比較例を例示することにより具体的に説明するが、本発明はこれらの実施例により何ら限定されるものではない。まず、実施例に用いた評価方法、及び評価基準を示す。 Hereinafter, the present invention will be specifically described by exemplifying Examples and Comparative Examples, but the present invention is not limited to these Examples. First, the evaluation method and evaluation criteria used in the examples are shown.

(1)低温安定性
(試験法)
0℃下における試料の透明度を下記評価基準により評価した。
(評価基準)
◎:低温安定性極めて良好 3ヶ月以上透明維持
×:低温安定性不良 3ヶ月未満透明維持
(1) Low temperature stability (test method)
The transparency of the sample at 0 ° C. was evaluated according to the following evaluation criteria.
(Evaluation criteria)
◎: Very good low temperature stability Maintains transparency for 3 months or more ×: Poor low temperature stability Maintains transparency for less than 3 months

(2)泡量
(試験法)
1000mL容器の撹拌機付き円筒形シリンダーに、実施例及び比較例の試料1%水溶液を80mL入れ、5000rpmで30秒間撹拌した後の泡容積を測定し、下記評価基準により評価した。
(評価基準)
◎:泡量極めて良好 泡容積500mL以上
○:泡量良好 泡容積400mL以上、500mL未満
△:泡量普通 泡容積300mL以上、400mL未満
×:泡量不良 泡容積300mL未満
(2) Foam amount (test method)
80 mL of 1% aqueous solutions of the samples of Examples and Comparative Examples were placed in a cylindrical cylinder with a stirrer in a 1000 mL container, and the foam volume after stirring at 5000 rpm for 30 seconds was measured and evaluated according to the following evaluation criteria.
(Evaluation criteria)
⊚: Very good foam volume 500 mL or more ○: Good foam volume 400 mL or more and less than 500 mL Δ: Normal foam volume 300 mL or more and less than 400 mL ×: Poor foam volume Less than 300 mL

(3)粘性
(試験法)
試料をブルックフィールド型粘度計において30℃の粘度を測定し、下記評価基準により評価した。
(評価基準)
◎:粘性極めて良好 2000mPa・s以上、2500mPa・s未満
○:粘性良好 1500mPa・s以上、2000mPa・s未満
2500mPa・s以上、3000mPa・s未満
△:粘性普通 1000mPa・s以上、1500mPa・s未満
3000mPa・s以上、3500mPa・s未満
×:粘性不良 1000mPa・s未満、3500mPa・s以上
(3) Viscosity (test method)
The sample was measured for viscosity at 30 ° C. with a Brookfield viscometer and evaluated according to the following evaluation criteria.
(Evaluation criteria)
⊚: Very good viscosity 2000 mPa · s or more, less than 2500 mPa · s ○: Good viscosity 1500 mPa · s or more, less than 2000 mPa · s
2500 mPa ・ s or more and less than 3000 mPa ・ s Δ: Viscous normal 1000 mPa ・ s or more and less than 1500 mPa ・ s
3000 mPa ・ s or more and less than 3500 mPa ・ s ×: Poor viscosity Less than 1000 mPa ・ s, 3500 mPa ・ s or more

(4)泡質
(試験法)
8名の専門パネルにより、試料使用時の泡の質感(クリーミィ性)を下記評価基準により評価した。
(評価基準)
◎:極めて良好 泡質が良いと答えた人が7人以上
○:良好 泡質が良いと答えた人が5人以上7人未満
△:普通 泡質が良いと答えた人が3人以上5人未満
×:不良 泡質が良いと答えた人が3人未満
(4) Foam quality (test method)
The texture (creaminess) of the foam when the sample was used was evaluated by the expert panel of 8 people according to the following evaluation criteria.
(Evaluation criteria)
◎: Very good 7 or more people answered that the foam quality is good ○: Good 5 or more and less than 7 people answered that the foam quality is good △: Normal 3 or more people answered that the foam quality is good 5 Less than 3 people ×: Poor Less than 3 people answered that the foam quality is good

<実施例1〜9及び比較例1〜10>
表1に示す実施例1〜9及び比較例1〜10の各処方による石けん系洗浄剤を調製し、これらを使用した時の透明性、泡量、泡質、粘性について調べ、その結果を表1に示した。
なお、以下全ての実施例及び比較例における配合量は質量%である。
<Examples 1 to 9 and Comparative Examples 1 to 10>
Soap-based cleaning agents according to the formulations of Examples 1 to 9 and Comparative Examples 1 to 10 shown in Table 1 were prepared, and the transparency, foam amount, foam quality, and viscosity when these were used were investigated, and the results are shown in the table. Shown in 1.
In addition, the compounding amount in all the following Examples and Comparative Examples is mass%.

Figure 0006817697
Figure 0006817697

表1より明らかなように、本発明の成分を用いた実施例1〜9の洗浄剤は比較例1〜10の洗浄剤に比べていずれも優れた性能を見出した。 As is clear from Table 1, the cleaning agents of Examples 1 to 9 using the components of the present invention were found to have excellent performance as compared with the cleaning agents of Comparative Examples 1 to 10.

Claims (2)

下記成分(A)〜(C)を含有することを特徴とする石けん系皮膚洗浄剤。
(A)エタノール 3〜10質量%
(B)直鎖脂肪酸メチルエタノールアミド型非イオン界面活性剤 3〜5質量%
(C)脂肪酸:脂肪酸のカリウム塩の質量比が1:99〜0:100である脂肪酸およびそのカリウム塩 15〜40質量%」
A soap-based skin cleanser containing the following components (A) to (C).
(A) Ethanol 3 to 10% by mass
(B) Linear fatty acid methylethanolamide type nonionic surfactant 3 to 5% by mass
(C) Fatty acid: fatty acid having a mass ratio of potassium salt of fatty acid of 1: 99 to 0: 100 and its potassium salt 15 to 40% by mass. "
直鎖脂肪酸メチルエタノールアミド型非イオン界面活性剤およびエタノールを、脂肪酸および脂肪酸のカリウム塩からなる石けん系皮膚洗浄剤に配合することにより、石けん系皮膚洗浄剤の低温環境下における透明性を維持する方法であって、
前記直鎖脂肪酸メチルエタノールアミド型非イオン界面活性剤は前記石けん系皮膚洗浄剤に対して3〜5質量%であり、
前記エタノールは前記石けん系皮膚洗浄剤に対して3〜10質量%であり、
前記脂肪酸および脂肪酸のカリウム塩は、脂肪酸:脂肪酸のカリウム塩の質量比が1:99〜0:100である前記脂肪酸および脂肪酸のカリウム塩を前記石けん系皮膚洗浄剤に対して15〜40質量%である、石けん系皮膚洗浄剤の低温環境下における透明性を維持する方法。
By blending a linear fatty acid methylethanolamide type nonionic surfactant and ethanol into a soap-based skin cleanser consisting of fatty acids and potassium salts of fatty acids, the transparency of the soap-based skin cleanser is maintained in a low temperature environment. It's a method
The linear fatty acid methylethanolamide type nonionic surfactant is 3 to 5% by mass with respect to the soap-based skin cleanser.
The ethanol Ri 3-10% by mass relative to the previous SL soap skin cleanser,
The fatty acid and the potassium salt of the fatty acid are such that the mass ratio of the fatty acid: the potassium salt of the fatty acid is 1:99 to 0: 100, and the potassium salt of the fatty acid and the fatty acid is 15 to 40% by mass with respect to the soap-based skin cleaning agent. in it, a method of maintaining a transparency in a low-temperature environment of soap-based skin cleanser.
JP2015242224A 2015-12-11 2015-12-11 Soap-based skin cleanser and storage stability improvement method Active JP6817697B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015242224A JP6817697B2 (en) 2015-12-11 2015-12-11 Soap-based skin cleanser and storage stability improvement method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015242224A JP6817697B2 (en) 2015-12-11 2015-12-11 Soap-based skin cleanser and storage stability improvement method

Publications (2)

Publication Number Publication Date
JP2017105737A JP2017105737A (en) 2017-06-15
JP6817697B2 true JP6817697B2 (en) 2021-01-20

Family

ID=59059039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015242224A Active JP6817697B2 (en) 2015-12-11 2015-12-11 Soap-based skin cleanser and storage stability improvement method

Country Status (1)

Country Link
JP (1) JP6817697B2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5857477B2 (en) * 1977-01-24 1983-12-20 カネボウ株式会社 Liquid shampoo composition
JPH11166198A (en) * 1997-12-03 1999-06-22 Nof Corp Liquid detergent composition
JP2006028048A (en) * 2004-07-14 2006-02-02 Noevir Co Ltd Gel-like or liquid detergent
JP2010241909A (en) * 2009-04-02 2010-10-28 Asahi Kasei Chemicals Corp Cleaning composition
JP5838816B2 (en) * 2011-01-14 2016-01-06 ライオン株式会社 Liquid skin cleanser products
JP5754644B2 (en) * 2011-11-04 2015-07-29 日油株式会社 Liquid detergent composition

Also Published As

Publication number Publication date
JP2017105737A (en) 2017-06-15

Similar Documents

Publication Publication Date Title
JP6144174B2 (en) Cleaning composition
JP2008179586A (en) Creamy skin cleanser composition
JP2013163659A (en) Skin detergent composition
JP6177651B2 (en) Cleaning composition
JP2014125435A (en) Skin cleanser composition
JP2013163658A (en) Skin detergent composition
JP6134837B1 (en) Liquid detergent composition
JP6990496B2 (en) Detergent composition
JP6812099B2 (en) Skin cleanser
JP6062242B2 (en) Concentrated liquid body cleaner composition
JP2012149198A (en) Skin detergent composition
JP6029973B2 (en) Skin cleanser composition
JP2014129244A (en) Skin cleanser composition
JP7204162B2 (en) detergent composition
JP2016094375A (en) Liquid detergent composition for former container
JP6795305B2 (en) Cleaning agent composition
JP6817697B2 (en) Soap-based skin cleanser and storage stability improvement method
JP6437289B2 (en) Cleaning composition
JP6828870B2 (en) Soap-based skin cleanser composition
JP6833320B2 (en) Skin cleanser composition
JP2020169128A (en) Hair cleanser composition
JP2008094724A (en) Skin cleanser composition
JP6828889B2 (en) Cleaning agent composition
JP4056948B2 (en) Gel-like composition
JP2021098677A (en) Detergent composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20181009

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190930

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190930

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200129

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200901

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200901

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20200929

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201027

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20201027

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20201105

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20201110

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201201

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201225

R150 Certificate of patent or registration of utility model

Ref document number: 6817697

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350